• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

SHH

Adoptive immunotherapy with regulatory T cells (Tregs) is usually a good

February 18, 2018 by Katherine Lewis Leave a Comment

Adoptive immunotherapy with regulatory T cells (Tregs) is usually a good treatment for allograft rejection and graft-versus-host disease (GVHD). the stage for using this strategy for producing antigen-specific Tregs for therapy of multiple illnesses. Intro The important part of regulatory Capital t cells (Tregs) in avoiding autoimmunity and managing reactions to alloantigens can be well … [Read more…]

Posted in: Blogging Tagged: BX-795, SHH

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by